Rhythm director receives RSUs and stock options
RHYTHM PHARMACEUTICALS director Jennifer L. Good reported equity awards and an option-related share issuance.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
RHYTHM PHARMACEUTICALS director Jennifer L. Good reported equity awards and an option-related share issuance. On June 24, 2026, she received 2,324 restricted stock units and options for 3,691 shares of common stock at an exercise price of $107.55 per share. The new RSUs and options fully vest on the earlier of June 24, 2027 or the day immediately before the company’s 2027 annual stockholder meeting, subject to her continued service. On June 23, 2026, 4,712 previously granted RSUs were converted into 4,712 shares of common stock, increasing her direct common stock holdings to 11,712 shares.
Insider Trade Summary
4,712 shares exercised/converted
Exercise
4 txns
Insider
GOOD JENNIFER L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,691 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 2,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 4,712 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,712 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,691 contracts (Direct);
Restricted Stock Units — 2,324 contracts (Direct);
Common Stock — 11,712 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. The restricted stock units are fully vested. The restricted stock units have no expiration date.
- F3. The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date.
- F4. The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
Key Figures
New RSU grant: 2,324 units
New stock options: 3,691 options at $107.55
RSUs converted: 4,712 shares
+2 more
5 metrics
New RSU grant
2,324 units
Restricted stock units granted on June 24, 2026
New stock options
3,691 options at $107.55
Option grant on June 24, 2026, exercise price per share
RSUs converted
4,712 shares
Common shares issued from RSU conversion on June 23, 2026
Post-transaction holdings
11,712 shares
Common stock directly held after June 23, 2026 transaction
Option expiration
June 23, 2036
Expiration date of 3,691-share stock option grant
Key Terms
Restricted Stock Units, Stock Option, exercise or conversion of derivative security, vesting
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option financial
"The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
vesting financial
"The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Rhythm Pharmaceuticals (RYTM) report for Jennifer L. Good?
Jennifer L. Good received equity awards and exercised RSUs. She was granted 2,324 restricted stock units and options for 3,691 shares, and 4,712 fully vested RSUs converted into 4,712 common shares, bringing her direct holdings to 11,712 shares.
What stock option grant did Jennifer L. Good receive from Rhythm Pharmaceuticals (RYTM)?
She received a stock option covering 3,691 shares of Rhythm Pharmaceuticals common stock at an exercise price of $107.55 per share. The options fully vest by June 24, 2027 or just before the 2027 annual stockholder meeting, subject to continued service.
What restricted stock unit (RSU) awards did Rhythm Pharmaceuticals (RYTM) grant to Jennifer L. Good?
On June 24, 2026, she was granted 2,324 restricted stock units, each representing one share of common stock. These RSUs fully vest by June 24, 2027 or the day before the 2027 annual meeting, subject to her continued service as disclosed.
Were any of Jennifer L. Good’s Rhythm Pharmaceuticals (RYTM) awards already fully vested?
Yes. The filing states that a block of restricted stock units was fully vested and had no expiration date. On June 23, 2026, 4,712 of those vested RSUs converted into 4,712 shares of Rhythm Pharmaceuticals common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
